Morepen Laboratories Limited (BOM: 500288)

Morepen Laboratories Statistics

Total Valuation

Morepen Laboratories has a market cap or net worth of INR 51.89 billion. The enterprise value is 52.01 billion.

Market Cap	51.89B
Enterprise Value	52.01B

Important Dates

The next estimated earnings date is Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Morepen Laboratories has 547.95 million shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding	547.95M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	-2.73%
Owned by Insiders (%)	9.36%
Owned by Institutions (%)	1.21%
Float	302.95M

Valuation Ratios

The trailing PE ratio is 41.25.

PE Ratio	41.25
Forward PE	n/a
PS Ratio	2.76
PB Ratio	5.71
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	44.19
EV / Sales	2.96
EV / EBITDA	28.81
EV / EBIT	31.49
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	3.42
Debt / EBITDA	0.16
Debt / FCF	n/a
Interest Coverage	36.06

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	12.48%
Revenue Per Employee	8.16M
Profits Per Employee	546,908
Employee Count	2,152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +147.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+147.84%
50-Day Moving Average	66.07
200-Day Moving Average	52.64
Relative Strength Index (RSI)	76.87
Average Volume (20 Days)	3,380,693

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Morepen Laboratories had revenue of INR 17.57 billion and earned 1.18 billion in profits. Earnings per share was 2.30.

Revenue	17.57B
Gross Profit	6.47B
Operating Income	1.65B
Pretax Income	1.63B
Net Income	1.18B
EBITDA	1.81B
EBIT	1.65B
Earnings Per Share (EPS)	2.30

Balance Sheet

The company has 169.45 million in cash and 289.99 million in debt, giving a net cash position of -120.54 million or -0.22 per share.

Cash & Cash Equivalents	169.45M
Total Debt	289.99M
Net Cash	-120.54M
Net Cash Per Share	-0.22
Equity (Book Value)	8.47B
Book Value Per Share	16.57
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 36.84%, with operating and profit margins of 9.40% and 6.70%.

Gross Margin	36.84%
Operating Margin	9.40%
Pretax Margin	9.28%
Profit Margin	6.70%
EBITDA Margin	10.27%
EBIT Margin	9.40%
FCF Margin	n/a

Dividends & Yields

Morepen Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.24%
Shareholder Yield	-0.24%
Earnings Yield	2.42%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a